ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species‐mediated induction of osteopontin gene expression by angiotensin II and interleukin‐1β in adult rat cardiac fibroblasts
- 15 September 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 198 (3), 399-407
- https://doi.org/10.1002/jcp.10419
Abstract
Osteopontin (OPN), also called cytokine Eta‐1, expressed in the myocardium co‐incident with heart failure plays an important role in post myocardial infarction (MI) remodeling by promoting collagen synthesis and accumulation. Angiotensin II (Ang II) and inflammatory cytokines are increased in the heart following MI. We studied the involvement of mitogen‐activated protein kinases (ERK1/2, JNKs, p38 kinase) and reactive oxygen species (ROS) in Ang II‐ and cytokine‐induced OPN gene expression in adult rat cardiac fibroblasts. Ang II alone increased OPN mRNA (3.3 ± 0.3‐folds; P < 0.05; n = 7), while interleukin‐1β (IL‐1β), tumor necrosis factor (TNF‐α), and interferon‐γ (IFN‐γ) had no effect. A combination of Ang II with IL‐1β or TNF‐α, not IFN‐γ, increased OPN mRNA more than Ang II alone. Nitric oxide donor, S‐nitrosoacetylpenicillamine (SNAP), alone or in combination with Ang II had no effect. Diphenylene iodonium (DPI), inhibitor of NAD(P)H oxidase, and tiron, superoxide scavenger, inhibited Ang II‐ and Ang II+ IL‐1β‐stimulated increases in OPN mRNA. Ang II activated ERK1/2 within 5 min of treatment, not JNKs. IL‐1β activated ERK1/2 and JNKs within 15 min of treatment. A combination of Ang II and IL‐1β activated ERK1/2 within 5 min of treatment. None of these stimuli activated p38 kinase. DPI almost completely inhibited Ang II + IL‐1β‐stimulated activation of ERK1/2, while partially inhibiting JNKs. PD98059, ERK1/2 pathway inhibitor, and SP600125, JNKs inhibitor, partially inhibited Ang II + IL‐1β‐stimulated increases in OPN mRNA. A combination of PD98059 and SP600125 almost completely inhibited Ang II + IL‐1β‐stimulated increases in OPN mRNA. Thus, Ang II alone increases OPN expression, while IL‐1β and TNF‐α act synergistically with Ang II to increase OPN mRNA possibly via NO independent mechanisms. The synergistic increase in OPN mRNA involves ROS‐mediated activation of ERK1/2 and JNKs, not P38 kinase, pathways in cardiac fibroblasts. J. Cell. Physiol. 198: 399–407, 2004Keywords
This publication has 52 references indexed in Scilit:
- MEK1/2–ERK1/2 Mediates α1-Adrenergic Receptor-stimulated Hypertrophy in Adult Rat Ventricular MyocytesJournal of Molecular and Cellular Cardiology, 2001
- p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated ApoptosisPublished by Elsevier ,2000
- Cellular Enrichment with Polyunsaturated Fatty Acids Induces an Oxidative Stress and Activates the Transcription Factors AP1 and NFκBBiochemical and Biophysical Research Communications, 1999
- Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy?The Journal of cell biology, 1998
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitro and in Vivo Cardiac HypertrophyJournal of Biological Chemistry, 1997
- Dissociation of p44 and p42 Mitogen-activated Protein Kinase Activation from Receptor-induced Hypertrophy in Neonatal Rat Ventricular MyocytesPublished by Elsevier ,1996
- Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial CellsPublished by Elsevier ,1995
- Reactive Oxygen Intermediates Mediate Angiotensin II-induced c-Jun•c-Fos Heterodimer DNA Binding Activity and Proliferative Hypertrophic Responses in Myogenic CellsJournal of Biological Chemistry, 1995
- Interaction of Osteopontin with Fibronectin and Other Extracellular Matrix MoleculesaAnnals of the New York Academy of Sciences, 1995